Back to Journals » ImmunoTargets and Therapy » Journal Metrics
ESCI
SJR OA
CiteScore
Impact Factor
![](https://www.dovepress.com/cr_data/cache/journal_image/138/cope/thumb_100_1000_100.jpg)
ImmunoTargets and Therapy
ISSN: 2253-1556
Usage:
- 40,125 Annual downloads/views
Speed/ acceptance:
- 54 days average from submission to first editorial decision
- 17 days average from editorial acceptance to publication
- 36% acceptance rate
Citation metrics:
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
- 6.2 ((Q1) 2023) Impact Factor *
- 8.1 (2023) 5 year Impact Factor
- 16.5 ((Q1) 2023) CiteScore
- 1.772 (2023) Source Normalized Impact per Paper (SNIP)
- 2.140 (2023) Scimago Journal & Country Rank (SJR)
- PubMed and PubMed Central (Immunotargets Ther)
- Scopus, from 2022
- Embase, from 2015
- Directory of Open Access Journals (DOAJ)
- The Open Access Initiative (OAIster)
*
- Emerging Sources Citation Index (ESCI)
For more details, please read our journal metrics summary.